Search Results

Rosiglitazone: Heart failure in an elderly patient: case report

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 30-30(1)

Publisher: Adis International

Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes

Authors: Derosa, G.; Tinelli, C.; Maffioli, P.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 12, December 2009 , pp. 1091-1099(9)

Publisher: Blackwell Publishing

Effects of rosiglitazone, a PPAR-γ agonist, on the contractility of bovine uterus in vitro

Authors: RIZZO, A.; SPEDICATO, M.; COSOLA, C.; MINOIA, G.; ROSCINO, M. T.; PUNZI, S.; SCIORSCI, R. L.

Source: Journal of Veterinary Pharmacology & Therapeutics, Volume 32, Number 6, December 2009 , pp. 548-551(4)

Publisher: Blackwell Publishing

Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes

Authors: Yun, S.I.; Park, H.O.; Kang, J.H.

Source: Journal of Applied Microbiology, Volume 107, Number 5, November 2009 , pp. 1681-1686(6)

Publisher: Blackwell Publishing

Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease

Authors: Belvisi, Maria G; Mitchell, Jane A

Source: British Journal of Pharmacology, Volume 158, Number 4, October 2009 , pp. 994-1003(10)

Publisher: Blackwell Publishing

Tobacco smoke affects expression of peroxisome proliferator-activated receptor-γ in monocyte/macrophages of patients with coronary heart disease

Authors: Amoruso, A; Gunella, G; Rondano, E; Bardelli, C; Fresu, LG; Ferrero, V; Ribichini, F; Vassanelli, C; Brunelleschi, S

Source: British Journal of Pharmacology, Volume 158, Number 5, November 2009 , pp. 1276-1284(9)

Publisher: Blackwell Publishing

Increased CV risk with rosiglitazone but not pioglitazone

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 2-2(1)

Publisher: Adis International

Baseline differences in A1C explain apparent differences in efficacy of sitagliptin, rosiglitazone and pioglitazone

Authors: Chapell, R.; Gould, A. L.; Alexander, C. M.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 11, November 2009 , pp. 1009-1016(8)

Publisher: Blackwell Publishing

The PPAR-γ agonist rosiglitazone facilitates Akt rephosphorylation and inhibits apoptosis in cardiomyocytes during hypoxia/reoxygenation

Authors: Kilter, H.; Werner, M.; Roggia, C.; Reil, J.-C.; Schäfers, H.-J.; Kintscher, U.; Böhm, M.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 11, November 2009 , pp. 1060-1067(8)

Publisher: Blackwell Publishing

News from ICPE

Source: Reactions, Volume 1, Number 1273, 2009-10-10 , pp. 4-5(2)

Publisher: Adis International

Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels

Authors: Chopra, B.; Georgopoulos, N. T.; Nicholl, A.; Hinley, J.; Oleksiewicz, M. B.; Southgate, J.

Source: Cell Proliferation, Volume 42, Number 5, October 2009 , pp. 688-700(13)

Publisher: Blackwell Publishing

Liraglutide: A Review of its Use in Type 2 Diabetes Mellitus

Authors: Croom, Katherine F.; McCormack, Paul L.

Source: Drugs, Volume 69, Number 14, 1 October 2009 , pp. 1985-2004(20)

Publisher: Adis International

Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control

Authors: Raskin; Lewin; Reinhardt; Lyness

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 10, October 2009 , pp. 947-952(6)

Publisher: Blackwell Publishing

Rosiglitazone maleate + metformin hydrochloride extend: review of an emerging compound

Authors: Cheng, Alice YY; Josse, Robert G

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 9, September 2009 , pp. 1365-1373(9)

Publisher: Informa Healthcare

Rosiglitazone inhibits high glucose-induced apoptosis in human umbilical vein endothelial cells through the PI3K/Akt/eNOS pathway

Authors: Wu, Jing; Lei, Min-Xiang; Xie, Xiao-Yun; Liu, Lan; She, Yan-Mei; Mo, Juan; Wang, Shan

Source: Canadian Journal of Physiology and Pharmacology, Volume 87, Number 7, 1 July 2009 , pp. 549-555(7)

Publisher: NRC Research Press

Oral Antidiabetic Agents: Anti-Atherosclerotic Properties Beyond Glucose Lowering?

Authors: Papanas, N.; Maltezos, E.

Source: Current Pharmaceutical Design, Volume 15, Number 27, September 2009 , pp. 3179-3192(14)

Publisher: Bentham Science Publishers

Effects of Rosiglitazone on Cardiac Function in CAPD Patients: A Tissue Doppler Study

Authors: Akcay, Ahmet; Acar, Gurkan; Sokmen, Abdullah; Sokmen, Gulizar; Dogan, Ekrem; Sayarlioglu, Hayriye; Citirik, Cagatay; Ucar, Mehmet Ali; Tuncer, Cemal

Source: Renal Failure, Volume 31, Number 6, July 2009 , pp. 464-469(6)

Publisher: Informa Healthcare

Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet

Authors: Raskin, P.; Lewin, A.; Reinhardt, R.; Lyness, W.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 9, September 2009 , pp. 865-873(9)

Publisher: Blackwell Publishing

Pioglitazone: better cardiac safety profile than rosiglitazone

Source: Reactions, Volume 1, Number 1267, 2009-08-29 , pp. 4-4(1)

Publisher: Adis International

All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells

Authors: Huang, Haiwen; Wu, Depei; Fu, Jinxiang; Chen, Guanghua; Chang, Weirong; Chow, Howard C. H.; Leung, Anskar Y. H.; Liang, Raymond

Source: European Journal of Haematology, Volume 83, Number 3, September 2009 , pp. 191-202(12)

Publisher: Blackwell Publishing